NTLA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,085,489.31

Intellia Therapeutics Insider Trading History Chart

Intellia Therapeutics Share Price & Price History

^$15.71

▼ -0.4 (-2.48%)

As of 11/14/2024 12:47 PM ET

Days: 30 | 90 | 365

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Get Your Free Gold Guide

Intellia Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/2/2024	Michael P Dube	CAO	Sell	2,012	$19.01	$38,248.12	47,012
7/1/2024	Eliana Clark	EVP	Sell	405	$22.93	$9,286.65	71,470
3/4/2024	James Basta	EVP	Sell	2,297	$32.99	$75,778.03	81,571
1/8/2024	Laura Sepp-Lorenzino	EVP	Sell	2,275	$28.87	$65,679.25	43,927
1/3/2024	David Lebwohl	EVP	Sell	5,843	$29.46	$172,134.78	54,372
1/3/2024	Glenn Goddard	CFO	Sell	5,365	$29.46	$158,052.90	40,585
1/3/2024	John M Leonard	CEO	Sell	19,223	$29.46	$566,309.58	846,486
10/31/2023	Muna Bhanji	Director	Sell	265	$23.90	$6,333.50	11,996
7/31/2023	Muna Bhanji	Director	Sell	265	$42.33	$11,217.45	12,261
7/6/2023	Muna Bhanji	Director	Sell	1,867	$39.30	$73,373.10	12,526
7/3/2023	Eliana Clark	EVP	Sell	360	$40.51	$14,583.60	45,146
6/20/2023	Eliana Clark	EVP	Sell	5,000	$45.00	$225,000.00	45,146
1/4/2023	Glenn Goddard	CFO	Sell	2,427	$37.21	$90,308.67	15,404
1/4/2023	John M Leonard	CEO	Sell	6,673	$37.21	$248,302.33	766,825
1/4/2023	Laura Sepp-Lorenzino	EVP	Sell	2,508	$37.21	$93,322.68	19,959
1/1/2022	Glenn Goddard	CFO	Sell	1,013	$112.24	$113,699.12
1/1/2022	John M Leonard	CEO	Sell	2,493	$112.25	$279,839.25
1/1/2022	Laura Sepp-Lorenzino	EVP	Sell	1,148	$112.25	$128,863.00

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Intellia Therapeutics (NASDAQ:NTLA)

88.77% of Intellia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Intellia Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Rockefeller Capital Management L.P.	76,038	$1.56M	0.0%	-24.7%	0.075%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	460,012	$9.45M	0.0%	-10.2%	0.452%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	26,905	$0.55M	0.0%	-2.5%	0.026%
11/13/2024	BNP Paribas Financial Markets	246,362	$5.06M	0.0%	+88.0%	0.242%
11/13/2024	FMR LLC	2,339,522	$48.08M	0.0%	+5.0%	2.297%
11/13/2024	D.A. Davidson & CO.	16,250	$0.33M	0.0%	+34.3%	0.016%
11/13/2024	The Manufacturers Life Insurance Company	53,545	$1.10M	0.0%	-1.2%	0.053%
11/13/2024	Horizon Kinetics Asset Management LLC	13,792	$0.28M	0.0%	-4.2%	0.014%
11/12/2024	Algert Global LLC	61,042	$1.25M	0.0%	-10.7%	0.060%
11/12/2024	Valence8 US LP	13,020	$0.27M	0.1%	N/A	0.013%
11/12/2024	Charles Schwab Investment Management Inc.	827,545	$17.01M	0.0%	+4.8%	0.815%
11/9/2024	Intech Investment Management LLC	28,203	$0.58M	0.0%	N/A	0.028%
11/8/2024	Grandfield & Dodd LLC	13,010	$0.27M	0.0%	N/A	0.013%
11/8/2024	Jennison Associates LLC	47,899	$0.98M	0.0%	+21.6%	0.047%
11/7/2024	LMR Partners LLP	71,100	$1.46M	0.0%	+35.3%	0.070%
11/7/2024	Quest Partners LLC	19,748	$0.41M	0.0%	+181.6%	0.019%
11/6/2024	Curi RMB Capital LLC	39,187	$0.81M	0.0%	+13.5%	0.039%
11/6/2024	KBC Group NV	3,753	$77K	0.0%	+37.3%	0.004%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	3,149,399	$64.72M	0.0%	-3.3%	3.100%
11/4/2024	State of New Jersey Common Pension Fund D	84,121	$1.73M	0.0%	-2.0%	0.083%
11/4/2024	Axxcess Wealth Management LLC	20,215	$0.42M	0.0%	+5.4%	0.020%
11/2/2024	Privium Fund Management B.V.	12,300	$0.25M	0.1%	N/A	0.012%
11/1/2024	Atria Investments Inc	23,099	$0.48M	0.0%	+24.3%	0.023%
11/1/2024	Lewis Asset Management LLC	66,308	$1.36M	1.0%	+42.5%	0.065%
10/31/2024	ARK Investment Management LLC	12,255,440	$251.85M	2.3%	+5.7%	12.065%
10/29/2024	Harbor Capital Advisors Inc.	79,205	$1.63M	0.1%	+71.0%	0.078%
10/29/2024	Capital Advisors Inc. OK	203,775	$4.19M	0.1%	-34.5%	0.201%
10/25/2024	SteelPeak Wealth LLC	19,106	$0.39M	0.0%	N/A	0.019%
10/25/2024	China Universal Asset Management Co. Ltd.	19,537	$0.40M	0.0%	+72.4%	0.019%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,674	$77K	0.0%	+27.6%	0.004%
10/23/2024	Values First Advisors Inc.	2,617	$54K	0.0%	N/A	0.003%
10/23/2024	Hennion & Walsh Asset Management Inc.	53,721	$1.10M	0.1%	+34.7%	0.056%
10/22/2024	Eastern Bank	2,000	$41K	0.0%	N/A	0.002%
10/18/2024	Raymond James & Associates	178,254	$3.66M	0.0%	-14.0%	0.185%
10/18/2024	Blue Trust Inc.	4,189	$94K	0.0%	+182.7%	0.004%
10/16/2024	nVerses Capital LLC	6,900	$0.14M	0.1%	N/A	0.007%
10/16/2024	IQ EQ FUND MANAGEMENT IRELAND Ltd	23,031	$0.47M	0.0%	+75.2%	0.024%
10/11/2024	Elmwood Wealth Management Inc.	67,774	$1.39M	0.6%	+0.9%	0.067%
10/11/2024	Woodstock Corp	25,550	$0.53M	0.1%	+102.6%	0.025%
10/10/2024	McGuire Investment Group LLC	71,301	$1.47M	0.2%	-1.0%	0.074%
10/5/2024	Handelsbanken Fonder AB	32,400	$0.67M	0.0%	+24.1%	0.034%
10/3/2024	SG Americas Securities LLC	24,144	$0.50M	0.0%	+289.6%	0.025%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	138,468	$3.10M	0.0%	-41.8%	0.144%
9/5/2024	Sanctuary Advisors LLC	21,614	$0.45M	0.0%	N/A	0.022%
8/16/2024	Capital Impact Advisors LLC	26,554	$0.59M	1.7%	-17.0%	0.028%
8/16/2024	Creative Planning	12,334	$0.28M	0.0%	-29.2%	0.013%
8/16/2024	Algert Global LLC	68,372	$1.53M	0.1%	+307.0%	0.071%
8/15/2024	Scientech Research LLC	47,101	$1.05M	0.2%	+133.0%	0.049%
8/15/2024	The Manufacturers Life Insurance Company	54,192	$1.21M	0.0%	-18.1%	0.056%
8/14/2024	Squarepoint Ops LLC	13,280	$0.30M	0.0%	-94.6%	0.014%
8/14/2024	EverSource Wealth Advisors LLC	1,753	$39K	0.0%	+763.5%	0.002%
8/14/2024	ProShare Advisors LLC	17,963	$0.40M	0.0%	-22.7%	0.019%
8/14/2024	Profund Advisors LLC	38,947	$0.87M	0.0%	-19.4%	0.040%
8/13/2024	Evolutionary Tree Capital Management LLC	36,262	$0.81M	0.8%	-1.4%	0.038%
8/13/2024	Ensign Peak Advisors Inc	36,019	$0.81M	0.0%	+23.5%	0.037%
8/13/2024	Thrivent Financial for Lutherans	30,333	$0.68M	0.0%	N/A	0.031%
8/13/2024	Sei Investments Co.	9,282	$0.21M	0.0%	+24.7%	0.010%
8/13/2024	Orchard Capital Management LLC	170,006	$3.81M	1.1%	-1.3%	0.176%
8/13/2024	Benjamin F. Edwards & Company Inc.	60,913	$1.36M	0.0%	+6,974.7%	0.063%
8/12/2024	XTX Topco Ltd	50,464	$1.13M	0.1%	+176.3%	0.052%
8/12/2024	Seven Eight Capital LP	56,413	$1.26M	0.1%	N/A	0.058%
8/12/2024	Hsbc Holdings PLC	36,631	$0.81M	0.0%	+6.0%	0.038%
8/12/2024	E Fund Management Co. Ltd.	12,665	$0.28M	0.0%	-12.4%	0.013%
8/10/2024	Axxcess Wealth Management LLC	19,171	$0.43M	0.0%	+15.5%	0.020%
8/9/2024	Renaissance Technologies LLC	38,700	$0.87M	0.0%	N/A	0.040%
8/9/2024	Dimensional Fund Advisors LP	1,324,561	$29.65M	0.0%	+8.1%	1.373%
8/8/2024	Federated Hermes Inc.	2,300,889	$51.49M	0.1%	+19.2%	2.385%
8/8/2024	American Century Companies Inc.	330,514	$7.40M	0.0%	+23.8%	0.343%
8/8/2024	State of New Jersey Common Pension Fund D	85,826	$1.92M	0.0%	-14.9%	0.089%
8/7/2024	Headlands Technologies LLC	3,148	$70K	0.0%	-61.3%	0.003%
8/6/2024	Quest Partners LLC	7,014	$0.16M	0.0%	-28.5%	0.007%
8/6/2024	Los Angeles Capital Management LLC	10,467	$0.23M	0.0%	-40.0%	0.011%
8/5/2024	Arizona State Retirement System	25,648	$0.57M	0.0%	+9.7%	0.027%
8/1/2024	Rhumbline Advisers	175,335	$3.92M	0.0%	+5.3%	0.182%
8/1/2024	Interchange Capital Partners LLC	20,145	$0.46M	0.2%	+84.7%	0.021%
7/31/2024	Commonwealth Equity Services LLC	27,537	$0.62M	0.0%	-20.4%	0.029%
7/30/2024	Pinnacle Associates Ltd.	251,078	$5.62M	0.1%	-1.8%	0.260%
7/29/2024	Principal Financial Group Inc.	12,860	$0.29M	0.0%	-37.4%	0.013%
7/29/2024	Panagora Asset Management Inc.	17,748	$0.40M	0.0%	N/A	0.018%
7/29/2024	IQ EQ FUND MANAGEMENT IRELAND Ltd	13,142	$0.29M	0.0%	N/A	0.014%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	27,587	$0.62M	0.0%	+21.2%	0.029%
7/26/2024	ARK Investment Management LLC	11,595,789	$259.51M	2.3%	+5.5%	12.020%
7/26/2024	Allspring Global Investments Holdings LLC	10,887	$0.24M	0.0%	+22.4%	0.011%
7/26/2024	Bank of New York Mellon Corp	364,306	$8.15M	0.0%	+0.6%	0.378%
7/22/2024	Krilogy Financial LLC	54,673	$1.22M	0.1%	+9.1%	0.057%
7/22/2024	Chevy Chase Trust Holdings LLC	1,042,625	$23.33M	0.1%	-3.0%	1.081%
7/20/2024	First Horizon Advisors Inc.	2,604	$58K	0.0%	+22.1%	0.003%
7/20/2024	Hennion & Walsh Asset Management Inc.	39,882	$0.89M	0.0%	N/A	0.041%
7/19/2024	Raymond James & Associates	207,295	$4.64M	0.0%	+34.1%	0.215%
7/19/2024	Sumitomo Mitsui Trust Holdings Inc.	3,257,689	$72.91M	0.1%	-4.2%	3.377%
7/19/2024	Intellectus Partners LLC	58,225	$1.30M	0.4%	+2.1%	0.060%
7/18/2024	Blue Trust Inc.	1,482	$33K	0.0%	+1,664.3%	0.002%
7/17/2024	AdvisorNet Financial Inc	5,100	$0.11M	0.0%	+63.5%	0.005%
7/9/2024	Harbor Capital Advisors Inc.	46,312	$1.04M	0.1%	-9.6%	0.048%
7/8/2024	Woodstock Corp	12,612	$0.28M	0.0%	N/A	0.013%
7/2/2024	GAMMA Investing LLC	2,645	$59K	0.0%	+1,322.0%	0.003%
6/4/2024	DekaBank Deutsche Girozentrale	75,000	$1.99M	0.0%	-4.0%	0.078%
5/29/2024	Opaleye Management Inc.	255,000	$7.02M	1.5%	+157.6%	0.264%
5/20/2024	Virtu Financial LLC	29,144	$0.80M	0.1%	N/A	0.030%
5/17/2024	Comerica Bank	37,105	$1.02M	0.0%	+853.6%	0.038%

Data available starting January 2016

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $15.71

$15.60

$16.28

50 Day Range

MA: $18.87

$14.22

$22.93

52 Week Range

Now: $15.71

$13.95

$34.87

Volume

705,634 shs

Average Volume

1,666,531 shs

Market Capitalization

$1.60 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.81

Who are the company insiders with the largest holdings of Intellia Therapeutics?: Intellia Therapeutics' top insider investors include:
John M Leonard (CEO)
James Basta (EVP)
Eliana Clark (EVP)
David Lebwohl (EVP)
Michael P Dube (CAO)
Laura Sepp-Lorenzino (EVP)
Glenn Goddard (CFO)
Muna Bhanji (Director)
Learn More about top insider investors at Intellia Therapeutics.
Who are the major institutional investors of Intellia Therapeutics?: Intellia Therapeutics' top institutional shareholders include:
ARK Investment Management LLC — 12.06%
Sumitomo Mitsui Trust Group Inc. — 3.10%
FMR LLC — 2.30%
Charles Schwab Investment Management Inc. — 0.81%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.45%
BNP Paribas Financial Markets — 0.24%
Learn More about top institutional investors of Intellia Therapeutics stock.
Which institutional investors are selling Intellia Therapeutics stock?: Within the previous quarter, NTLA stock was sold by these institutional investors:
Sumitomo Mitsui Trust Group Inc.
Capital Advisors Inc. OK
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Walleye Trading LLC
Raymond James & Associates
Rockefeller Capital Management L.P.
Walleye Capital LLC
PEAK6 Investments LLC
In the previous year, company insiders that have sold Intellia Therapeutics company stock include:
John M Leonard (CEO)
James Basta (EVP)
Eliana Clark (EVP)
David Lebwohl (EVP)
Michael P Dube (CAO)
Laura Sepp-Lorenzino (EVP)
Glenn Goddard (CFO)
Learn More investors selling Intellia Therapeutics stock.
Which institutional investors are buying Intellia Therapeutics stock?: Within the last quarter, NTLA stock was purchased by institutional investors including:
ARK Investment Management LLC
BNP Paribas Financial Markets
FMR LLC
Charles Schwab Investment Management Inc.
Harbor Capital Advisors Inc.
Intech Investment Management LLC
Lewis Asset Management LLC
SteelPeak Wealth LLC